Paul Herrling

First Person | Paul Herrling Courtesy of Ruder Finn When Paul Herrling didn't do his homework at his Swiss boarding school, the facility's science-loving director devised unusual punishments. The then-teenaged Herrling, now Novartis' head of corporate research, had to catalog the man's collection of crickets, which the director had recovered from ice, ages old, on a nearby Italian mountain. "He was studying glacial repopulation," says Herrling. The discipline, and the fervor of the direct


Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

When Paul Herrling didn't do his homework at his Swiss boarding school, the facility's science-loving director devised unusual punishments. The then-teenaged Herrling, now Novartis' head of corporate research, had to catalog the man's collection of crickets, which the director had recovered from ice, ages old, on a nearby Italian mountain. "He was studying glacial repopulation," says Herrling.

The discipline, and the fervor of the director's science lectures, opened Herrling's eyes to biology. "With every lesson, I was learning absolutely astonishing stuff," he explains.

Herrling was hired in 1975 when the Swiss government, he says, was telling drug houses to hire their own instead of the better-trained English scientists. Multilingual and well traveled, Herrling visits Singapore six times a year, where he directs the newly established Novartis Institute for Tropical Diseases. He spent his youth in Alexandria, Egypt.

He makes the most of his time on the road. An accomplished antiquarian, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio